Nathanael James Yates. (2016) Schizophrenia: the role of sleep and circadian rhythms in regulating dopamine and psychosis. Reviews in the Neurosciences 27:7, pages 669-687.
Crossref
Armando Morera-Fumero & Pedro Abreu-Gonzalez. (2013) Role of Melatonin in Schizophrenia. International Journal of Molecular Sciences 14:5, pages 9037-9050.
Crossref
F. López-Muñoz, J.D. Molina, G. Rubio & C. Alamo. (2011) An historical view of the pineal gland and mental disorders. Journal of Clinical Neuroscience 18:8, pages 1028-1037.
Crossref
Armando L. Morera, Pedro Abreu-Gonzalez & Manuel Henry. 2009. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes
107
119
.
Giuseppe Bersani, Alessandra Garavini, Angela Iannitelli, Adele Quartini, Maurizio Nordio, Claudio Di Biasi & Paolo Pancheri. (2002) Reduced pineal volume in male patients with schizophrenia: no relationship to clinical features of the illness. Neuroscience Letters 329:2, pages 246-248.
Crossref
Claudia Pacchierotti, Sonia Iapichino, Letizia Bossini, Fulvio Pieraccini & Paolo Castrogiovanni. (2001) Melatonin in Psychiatric Disorders: A Review on the Melatonin Involvement in Psychiatry. Frontiers in Neuroendocrinology 22:1, pages 18-32.
Crossref
Palmiero Monteleone, Mario Maj, Mario Fusco, Dargut Kemali & Russel J. Reiter. (1992) Depressed nocturnal plasma melatonin levels in drug-free paranoid schizophrenics. Schizophrenia Research 7:1, pages 77-84.
Crossref
Csaba M. Banki. (1991) Serotonin: La chica de moda in biological psychiatry?. Biological Psychiatry 29:10, pages 949-952.
Crossref
C.P Maurizi. (1990) The therapeutic potential for tryptophan and melatonin: Possible roles in depression, sleep, Alzheimer's disease and abnormal aging. Medical Hypotheses 31:3, pages 233-242.
Crossref
Pekka Peura, Jodie V. Johnson, Richard A. Yost & Kym F. Faull. (2006) Concentrations of Tryptoline and Methtryptoline in Rat Brain. Journal of Neurochemistry 52:3, pages 847-852.
Crossref
C.P. Maurizi. (1988) Why not treat melancholia with melatonin and tryptophan and treat seasonal affective disorders with bright light?. Medical Hypotheses 27:4, pages 271-276.
Crossref
Andrew Miles & David R.S. Philbrick. (1988) Melatonin and psychiatry. Biological Psychiatry 23:4, pages 405-425.
Crossref
Pekka Peura, Kym F. Faull & Jack D. Barchas. (1988) Determination of tryptamine in rat brain by gas chromatography—mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 6:6-8, pages 821-825.
Crossref
Bary W. Wilson. (2005) Chronic exposure to elf fields may induce depression. Bioelectromagnetics 9:2, pages 195-205.
Crossref
C.P. Maurizi. (1987) The function of dreams (REM sleep): Roles for the hippocampus, melatonin, monoamines, and vasotocin. Medical Hypotheses 23:4, pages 433-440.
Crossref
Charles P. Maurizi. (1985) Could supplementary dietary tryptophan and taurine prevent epileptic seizures?. Medical Hypotheses 18:4, pages 411-415.
Crossref
Michael A. Collins. 1983.
329
358
.
Mark D. Rollag. (1982) Ability of tryptophan derivatives to mimic melatonin's action upon the Syrian hamster reproductive system. Life Sciences 31:24, pages 2699-2707.
Crossref
G.M. Brown & L.P. Niles. 1982. Clinical Neuroendocrinology. Clinical Neuroendocrinology
205
264
.
Klaus J. Fehske, Walter E. MÜller, Karl L. Platt & Angelika E. Stillbauer. (1981) Inhibition of benzodiazepine receptor binding by several tryptophan and indole derivatives. Biochemical Pharmacology 30:21, pages 3016-3019.
Crossref
Richard A. Glennon. (1981) Serotonin receptor interactions of harmaline and several related β-carbolines. Life Sciences 29:8, pages 861-865.
Crossref
Louise Mead Riscalla. (1980) Blindness and schizophrenia. Medical Hypotheses 6:12, pages 1327-1328.
Crossref
Ilkka Kari, Pekka Peura & Mauno M. Airaksinen. (1980) Quantitative gas chromatographic mass spectrometric determination of 1,2,3,4-tetrahydro-β-carboline in human plasma and platelets. Biological Mass Spectrometry 7:11-12, pages 549-552.
Crossref
Steven A Barker, G.F Carl & John A Monti. (1980) Hyperformaldehydism: A unifying hypothesis for the major biochemical theories of schizophrenia. Medical Hypotheses 6:7, pages 671-686.
Crossref
Hannu Komulainen, Jouko Tuomisto, Mauno M. Airaksinen, Ilkka Kari, Pekka Peura & Liisa Pollari. (2009)
Tetrahydro‐β‐carbolines and Corresponding Tryptamines:
In Vitro
Inhibition of Serotonin, Dopamine and Noradrenaline Uptake in Rat Brain Synaptosomes
. Acta Pharmacologica et Toxicologica 46:4, pages 299-307.
Crossref
James R.F. Allen & Bo R. Holmstedt. (1980) The simple β-carboline alkaloids. Phytochemistry 19:8, pages 1573-1582.
Crossref
D. F. Horrobin, M. S. Manku, M. Oka & S. C. Cunnane. 1980. Biochemistry of Schizophrenia and Addiction. Biochemistry of Schizophrenia and Addiction
3
17
.
D.F Horrobin. (1979) SCHIZOPHRENIA: RECONCILIATION OF THE DOPAMINE, PROSTAGLANDIN, AND OPIOID CONCEPTS AND THE ROLE OF THE PINEAL. The Lancet 313:8115, pages 529-531.
Crossref
P.E. Mullen, C. Linsell, R.E. Silman, R. Edwards, S. Carter, J. Hooper, R. Leone, Carol Laude, I. Smith & P. Towell. 1979. The Coming Age of Psychosomatics. The Coming Age of Psychosomatics
357
376
.
Thomas F. Spande. 1979. Chemistry of Heterocyclic Compounds. Chemistry of Heterocyclic Compounds
1
355
.
M. M. Airaksinen, J‐T. Huang, B. T. Ho, D. Taylor & K. Walker. (2009) The Uptake of 6‐Methoxy‐1,2,3,4‐Tetrahydro‐β‐carboline and its Effect on 5‐Hydroxytryptamine Uptake and Release in Blood Platelets. Acta Pharmacologica et Toxicologica 43:5, pages 375-380.
Crossref
A. C. Greiner & S. C. Chan. (1978) Melatonin Content of the Human Pineal Gland. Science 199:4324, pages 83-84.
Crossref
P.E. Mullen, C. Linsell, R.E. Silman, R. Edwards, S. Carter, J. Hooper, R. Leone, Carol Laude, I. Smith & P. Towell. (1978) The human pineal new approaches and prospects. Journal of Psychosomatic Research 22:4, pages 357-376.
Crossref
Leo E. Hollister. 1978. Stimulants. Stimulants
389
424
.
P. E. Mullen & R. E. Silman. (2009) The pineal and psychiatry: a review. Psychological Medicine 7:3, pages 407-417.
Crossref
ALEXANDER T. SHULGIN. 1976. Psychopharmacological Agents. Psychopharmacological Agents
59
146
.
Ralf G. Rahwan. (1975) Toxic effects of ethanol: Possible role of acetaldehyde, tetrahydroisoquinolines, and tetrahydro-β-carbolines. Toxicology and Applied Pharmacology 34:1, pages 3-27.
Crossref
Ralf G. Rahwan. (1975) Speculations on the biochemical pharmacology of ethanol. Life Sciences 16:4, pages 617-633.
Crossref
Ralf G. Rahwan. (1974) Speculations on the biochemical pharmacology of ethanol. Life Sciences 15:4, pages 617-633.
Crossref
Michael J. Walsh. (1973) BIOGENESIS OF BIOLOGICALLY ACTIVE ALKALOIDS FROM AMINES BY ALCOHOL AND ACETALDEHYDE. Annals of the New York Academy of Sciences 215:1 Alcoholism an, pages 98-110.
Crossref
. (1972) Alcohol Addiction: a Biochemical Approach. The Lancet 300:7766, pages 24-25.
Crossref
D. J. Boet. (1970) Toxic effects of phenothiazines on the eye. Documenta Ophthalmologica 28:1, pages 1-69.
Crossref
Beng T. Ho, William M. McIsaac, Rong An, Robert T. Harris, K. E. Walker, Patricia M. Kralik & Mauno M. Airaksinen. (1970) Biological activities of some 5-substituted N,N-dimethyltryptamines, ?-methyltryptamines, and gramines. Psychopharmacologia 16:5, pages 385-394.
Crossref
J. Villablanca & F. Riob�. (1970) Electroencephalographic and behavioral effects of harmaline in intact cats and in cats with chronic mesencephalic transection. Psychopharmacologia 17:4, pages 302-313.
Crossref
E. E. Herkert & W. Keup. 1970. Origin and Mechanisms of Hallucinations. Origin and Mechanisms of Hallucinations
261
274
.
J. W. Affleck, A. J. Cooper, A. D. Forrest, J. R. Smythies & A. K. Zealley. (2018) Penicillamine and Schizophrenia—A Clinical Trial. British Journal of Psychiatry 115:519, pages 173-176.
Crossref
W.B. QUAY. 1969. Physiology and Pathology of Adaptation Mechanisms. Physiology and Pathology of Adaptation Mechanisms
508
550
.
. 1968. Biological Psychiatry. Biological Psychiatry
25
49
.
V. S. Johnston & R. J. Bradley. 1968. Recent Advances in Biological Psychiatry. Recent Advances in Biological Psychiatry
74
99
.
A. Hoffer & H. Osmond. 1967. The Hallucinogens. The Hallucinogens
443
516
.
LOUISE H. GREENBERG, R.F.J. McCANDLESS & MAXWELL GORDON. 1967. Psychopharmacological Agents. Psychopharmacological Agents
249
282
.
H. Weil‐Malherbe. 1967. Advances in Enzymology and Related Areas of Molecular Biology. Advances in Enzymology and Related Areas of Molecular Biology
479
553
.
William M. McIsaac & Vicente Estevez. (1966) Structure-action relationship of β-carbolines as monoamine oxidase inhibitors. Biochemical Pharmacology 15:10, pages 1625-1627.
Crossref
G.A. Nicolson, A.C. Greiner, W.J.G. Mcfarlane & R.A. Baker. (1966) EFFECT OF PENICILLAMINE ON SCHIZOPHRENIC PATIENTS. The Lancet 287:7433, pages 344-347.
Crossref
AnthonyC. Greiner & GeorgeA. Nicolson. (1965) SCHIZOPHRENIA-MELANOSIS. The Lancet 286:7423, pages 1165-1167.
Crossref
J.R. Smythies. 1965. Horizons in Neuro-Psychopharmacology. Horizons in Neuro-Psychopharmacology
1
38
.
Sven Dahl. (1964) Reserpine and Asthma (with a review of the Literature). International Journal of Clinical Practice 18:8, pages 453-461.
Crossref
G. FARRELL, W.M. MCISAAC & A.N. TAYLOR. 1964. Hormonal Steroids Biochemistry, Pharmacology, and Therapeutics. Hormonal Steroids Biochemistry, Pharmacology, and Therapeutics
141
147
.
Lembitu Reio, Harry Boström & Robert G. Heath. (2007) ON THE EXCRETION OF SULPHATE ACCEPTORS BY SCHIZOPHRENIC AND NORMAL SUBJECTS. Acta Psychiatrica Scandinavica 39:4, pages 634-651.
Crossref
J. R. Gillette, R. V. Heinzelman, J. Szmuszkovicz, H. G. Leemann, K. Stich, M. Thomas, M. Martin-Smith, T. Khatoon & W. KunzR. V. Heinzelman & J. Szmuszkovicz. 1963. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques
75
150
.
William M. McIsaac, Philip A. Khairallah & Irvine H. Page. (1961) 10-Methoxyharmalan, a Potent Serotonin Antagonist Which Affects Conditioned Behavior. Science 134:3480, pages 674-675.
Crossref
William M. McIsaac. (1961) Formation of 1-methyl-6-methoxy-1,2,3,4-tetrahydro-2-carboline under physiological conditions. Biochimica et Biophysica Acta 52:3, pages 607-609.
Crossref